Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II ,III Randomized Double Blind Parallel Arms Clinical Trial of Potential Role of Gum Arabic ( Acacia Senegal) as Immunomodulatory Agent Among COVID 19 Patients in Sudan

NCT04381871 is registered in ClinicalTrials.gov with Al-Neelain University as lead sponsor.

NCT NCT04381871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04381871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II ,III Randomized Double Blind Parallel Arms Clinical Trial of Potential Role of Gum Arabic ( Acacia Senegal) as Immunomodulatory Agent Among COVID 19 Patients in Sudan
Lead sponsor
Al-Neelain University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 1, 2020
Completion date
September 1, 2020
Enrollment
110 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19